Ginkgo Bioworks Holdings (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -129,297 | -76,059 | -312,763 | -232,012 | -151,257 |
| Depreciation Amortization | 25,114 | 12,799 | 55,600 | 45,327 | 30,071 |
| Income taxes - deferred | N/A | N/A | -1,364 | N/A | N/A |
| Accounts receivable | 3,471 | -242 | -1,473 | 345 | 2,198 |
| Accounts payable and accrued liabilities | N/A | N/A | -2,992 | 16,991 | N/A |
| Other Working Capital | -27,324 | -14,178 | -44,088 | -20,501 | -30,984 |
| Other Operating Activity | 37,077 | 30,994 | 136,021 | 66,469 | 58,197 |
| Operating Cash Flow | $-90,959 | $-46,686 | $-171,059 | $-123,381 | $-91,775 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,552 | -1,933 | -7,091 | -7,660 | -7,660 |
| Purchase Of Investment | -127,445 | -83,161 | -259,147 | -328,239 | -320,132 |
| Sale Of Investment | 166,168 | 108,178 | N/A | N/A | 64,958 |
| Other Investing Activity | 48 | 48 | 25,949 | 511 | 262 |
| Investing Cash Flow | $34,219 | $23,132 | $-240,289 | $-335,388 | $-262,572 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -19 | -19 | -354 | -329 | -305 |
| Common Stock Issued | N/A | N/A | N/A | 10,317 | N/A |
| Other Financing Activity | 16,489 | 0 | 18,129 | -355 | 0 |
| Financing Cash Flow | $16,470 | $-19 | $17,775 | $9,633 | $-305 |
| Exchange Rate Effect | -86 | -129 | 201 | 353 | 260 |
| Beginning Cash Position | 212,371 | 212,371 | 605,743 | 605,743 | 605,743 |
| End Cash Position | 172,015 | 233,838 | 212,371 | 156,960 | 251,351 |
| Net Cash Flow | $-40,356 | $21,467 | $-393,372 | $-448,783 | $-354,392 |
| Free Cash Flow | |||||
| Operating Cash Flow | -90,959 | -46,686 | -171,059 | -123,381 | -91,775 |
| Capital Expenditure | -4,552 | -1,933 | -7,665 | -7,660 | -7,660 |
| Free Cash Flow | -95,511 | -48,619 | -178,724 | -131,041 | -99,435 |